TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
Input di momentum (manager comparabili):
ampiezza dei detentori -30.0% ·
flusso azionario -25.4% ·
nuove posizioni nette -20.0%
· formula
Broad distribution: falling shares and fewer holders
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q1 2025
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.93M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | n/a | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | n/a |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | n/a |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | n/a | 5.37M | $12.04M | n/a | n/a |
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 4.57M | Nuovo | $6.35M | 0.0% | New | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passivo) | 3.66M | +2.6% | $5.10M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | State Street Global Advisors ✦ (passivo) | 3.23M | -50.1% | $4.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.77M | +1069.2% | $2.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 625.20K | +6.8% | $869,025 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 216.61K | -70.9% | $301,089 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 107.90K | +325.6% | $149,979 | 0.0% | ▲ Add | 3 | SEC ↗ ×5 |
| 8 | T. Rowe Price ✦ | 74.03K | +13.3% | $103,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
Nuovi acquirenti
| Point72 Asset Management | $6.35M | 0.0% |
Uscito
| Adage Capital Partners | $8.65M | era 0.0% |
| Norges Bank | $2.53M | era 0.0% |
| Renaissance Technologies | $1.52M | era 0.0% |
| Marshall Wace | $238,932 | era 0.0% |
| Two Sigma Investments | $21,279 | era 0.0% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 190 detentori, 265.00M azioni, $1.21B dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.